Moderna | Financial Buzz

Biotechnology Healthcare Investing News Life Style Market News Your Environment

Moderna Anticipates to Have Coronavirus Vaccine Answers by November

Rebecca Urena09/17/202009/17/2020

3442

Moderna’s (NASDAQ: MRNA) CEO, Stephane Bancel, announced Thursday that the company should have an answer as to whether its coronavirus vaccine is successful or not by November. “If the...

Biotechnology Healthcare Investing News Market News

Biotech Sector Pursues a Vaccine as COVID-19 Cases Continue to Rise

Danny Abramov06/26/2020

11369

The number of new COVID-19 cases per day in the United States continues to rise. While significantly expanded testing probably accounts for the increase in numbers, some experts claim...

Investing News Market News

Catalent and Moderna Report Collaboration to Manufacture Moderna’s Coronavirus Vaccine Candidate

Bryan Shin06/25/2020

5271

Moderna, Inc. (NASDAQ: MRNA) and Catalent, Inc. (NYSE: CTLT) have announced a collaboration to large scale, commercial fill-finish manufacturing of Moderna’s mRNA-based COVID-19 vaccine candidate (mRNA-1273) at Catalent’s biologics...

Tag: Moderna

Moderna Anticipates to Have Coronavirus Vaccine Answers by November

Biotech Sector Pursues a Vaccine as COVID-19 Cases Continue to Rise

Catalent and Moderna Report Collaboration to Manufacture Moderna’s Coronavirus Vaccine Candidate

ABOUT US

INSTAGRAM

Tweets